Innolake Biopharm
PrivateLast Round
Series A
Extension
Jun 5, 2023
Total Funding Raised
$53.99M
Company Overview
Innolake Biopharm is a clinical-stage biotechnology company that develops therapeutic drugs for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innolake Biopharm Comparables
Compare Innolake Biopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediLink Therapeutics | 88% | |
| Minghui Pharmaceutical | 86% | |
| Duality Biotherapeutics Inc | 85% |
Innolake Biopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 5, 2023 | ||||
| Early Funding | Apr 6, 2021 |
Innolake Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | Series A Extension |
| Hangzhou Heda Industry Fund | Series A Extension |
| Huagai Capital | Early Funding |
| CDH Investments | Early Funding |
| Zhongbo Venture Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2023
$14M round led by Zhongbo Juli and Hangzhou Heda Industry Fund.
- Apr 6, 2021
$40M raised with participation from CDH Investments and Huagai Capital.
Innolake Biopharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Innolake Biopharm's valuation, stock price, and market status.
Is Innolake Biopharm a public or private company?
Innolake Biopharm is a private company.
What is the current stock price of Innolake Biopharm?
Innolake Biopharm is a private company with no public stock price. No recent secondary market data is available.
How much is Innolake Biopharm worth (valuation)?
Valuation information for Innolake Biopharm is not publicly available.
Can I buy Innolake Biopharm stock?
Innolake Biopharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Innolake Biopharm's last funding round?
Innolake Biopharm's most recent funding round was Series A Extension on June 5, 2023.
Who are the main investors in Innolake Biopharm?
Key investors in Innolake Biopharm include Hangzhou Heda Industry Fund, Zhongbo Venture Capital.
Will Innolake Biopharm IPO soon?
No public IPO plans have been announced for Innolake Biopharm.
How can I track Innolake Biopharm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innolake Biopharm's secondary market activity and sign up for updates.